- Home Page
- Company Profile
-
Our Products
- Pharmaceutical Products
-
Cardiac Medicine
- Telmisartan 40
- TELMISARTAN & METOPROLOL
- Cilnidipine Tablet
- Ivabradine Tablet
- Pitavastatin And Ezetimibe Tablet
- Irbesartan Cilnidipine Tablet
- Cilnidipine And Irbesartan Tablet
- Moxonidine Tablets
- S - Amlodipine Tablet
- Ivabradine Tablet
- Bisorprolol Fumarate & S-Amlodipine Besilate Tablets
- Telmisartan and Cilnidipine Tablet
- Telmisartan And Amlodipine
- Telmisartan and Chlorothalidone
- Lopinavir & Ritonavir
- Dabigatron capsule
- Ivabradine Tablets
- Bisoprolol Fumarate Tablets
- Moxonidine Tablets
- Urology Medicines
- Diabetic Medicines
- Orthopedic Medicines
- Gastroenterology Medicines
- Anti-asthmatic Medicines
- Multivitamin Medicines
- General Medicines
- Derma Medicines
-
Pharmaceuticals
- Contact Us
X
Teneligliptin and Metformin tablet
73.80 INR
Product Details:
- Appearance Tablet
- Storage Instructions Dry Place
- Supply Ability : Per Month
- Click to view more
X
Price And Quantity
- 73.80 - 123.00 INR
- 73.80 INR
- 10 BOX Box
Product Specifications
- Dry Place
- Tablet
Trade Information
- Per Month
- Days
- Yes
- Sample costs shipping and taxes has to be paid by the buyer
- As per requirement
- All India
Product Description
Teneligliptin is a class of anti-diabetic drug known as gliptins for the treatment of Type 2 diabetes mellitus. Tenegliptin increases the amount of insulin released by Pancreas, which in turns lowers the blood glucose level.
Other Details:
- Usage: Clinical,Hospital
- Dosage Guidelines: As per Dr Advice
- Pack Type: Box
- Size: 10 x 10 Tablet
- Grade standard: Medicine Grade
- Suitable For : Suitable For all
Other Products in 'Diabetic Medicines' category
Contact Details
GLOBUS LABS
309, 3rd Floor, Gupta Tower, Azadpur Commercial Complex, Azadpur,Delhi - 110033, India
Mr H. P. Sharma
(Marketing Manager)
|
|
|
 |
|
Getdistributors.comSME TimesBlog
India's Largest B2B Marketplace, Connecting Buyers and Sellers.
Privacy Policy- Terms of Use © 1999-2017 Infocom Network Limited. All rights reserved.